Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-077650
Filing Date
2025-08-13
Accepted
2025-08-13 17:16:56
Documents
15
Effectiveness Date
2025-08-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2523056d1_s8.htm S-8 64547
2 EXHIBIT 5.1 tm2523056d1_ex5-1.htm EX-5.1 10732
3 EXHIBIT 23.1 tm2523056d1_ex23-1.htm EX-23.1 2228
4 EX-FILING FEES tm2523056d1_ex-filingfees.htm   iXBRL EX-FILING FEES 22015
5 GRAPHIC tm2523056d1_ex5-1img01.jpg GRAPHIC 8809
  Complete submission text file 0001104659-25-077650.txt   243982

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2523056d1_ex-filingfees_htm.xml XML 8959
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289588 | Film No.: 251212922
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)